Sana Biotechnology Announces FDA Clearance of Investigational New Drug Application for SC291, a Hypoimmune-modified, CD19-targeted Allogeneic CAR T Therapy for Patients with B-Cell Malignancies January 26, 2023
Firefly Health Welcomes Former Massachusetts Lt. Governor Karyn Polito to its Advisory Council January 25, 2023
Carrot Fertility Exceeds National Benchmarks for Fertility Success, Publishes New, Independently Validated Outcomes Study January 18, 2023
Structure Therapeutics Appoints Industry Leaders Eric Dobmeier and Joanne Waldstreicher to its Board of Directors January 18, 2023
Whatfix ISV Partnership Program Grows Rapidly, Empowering Software Providers to Deliver Better User Experience and Accelerate Customer Adoption January 12, 2023
Jefferson County to Use Eleos Health’s Augmented Intelligence to Give Therapists More Time to Serve Those With Mental Illness January 12, 2023
Insilico Medicine announces positive topline results of the New Zealand Phase 1 trial of INS018_055, an AI-designed drug for an AI-discovered target January 10, 2023